Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. (Q47743493)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. |
scientific article |
Statements
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease (English)
Madhav V Dhodapkar
Keren Osman
Julie Teruya-Feldstein
Daniel Filippa
Kristin Iversen
Denise Kolb
Matthew D Geller
Hani Hassoun
Tarun Kewalramani
Raymond L Comenzo
Keren Coplan
Achim A Jungbluth